At Broadstreet we deliver solutions not formulas.

An open-minded and client-focused approach means our customized design process delivers the solution you need.

Broadstreet is a boutique technology solutions company for the health economics and outcomes research community. We were founded on the idea that good research begins with a solid client-consultant relationship. We consistently deliver high-quality technology solutions for two key reasons.

We only take on work we know we’re great at and, more importantly, we put the client at the center of the process.

Epidemiology & Observational Studies

Our team designs and conducts observational studies used to characterize the clinical landscape and burden of disease for a product’s indication; estimate treatment effectiveness or safety; or parameterize economic models.

Evidence Synthesis

We provide rigorously conducted literature reviews following best practices guidelines, coupled with robust quantitative or qualitative evidence syntheses, to address a variety of research questions.

Health Economics

Our team develops HEOR models for a variety of contexts and settings. Our approach to model development and adaptation is to work with clients to design a customized structure and interface, in accordance with submission requirements and guidelines for best practice.


HEOR Technology Services

We have the IT capability to undertake big solutions. We create a variety of high-quality, custom digital products for our clients. These include tools that ensure for timely and accurate data collection, digital models that facilitate data analysis, and novel tools for dissemination of study findings.

Want to learn more?

Latest News

Broadstreet at ISPOR 2021 Virtual

This year at ISPOR 2021 Virtual, Broadstreet and our friends at Avalon Health Economics will be facilitating a workshop about how public health data can feed into valuations of COVID-19 interventions. The session: Lost in Transmission: Analytic Applications of Public […]

Broadstreet supports the fight against rare diseases

Sunday is Rare Disease Day! The last day of every February is dedicated to raising awareness among the general public and decision-makers about rare diseases, and their impact on patients’ lives. This is a cause near and dear to our […]

Broadstreet, the original John Snow, and lessons for the time of COVID

What’s in a name? How about a constant reminder of the ethos that inspires Broadstreet. As we start 2021 full of hope for a better year than the last, at Broadstreet we have been reflecting on the key contributions epidemiology […]

See all news